Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure

[1]  M. Tzvetkov,et al.  A Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor Heterodimer Physically Interacts with the Transcriptional Activator PAX6 to Inhibit Glucagon Gene Transcription , 2008, Molecular Pharmacology.

[2]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[3]  M. Hafner,et al.  Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance , 2006, Nature.

[4]  A. Salehi,et al.  Paradoxical Stimulation of Glucagon Secretion by High Glucose Concentrations , 2006, Diabetes.

[5]  C. Duve.  Le lysosome a cinquante ans , 2005 .

[6]  M. Oppermann,et al.  G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers* , 2005, Journal of Biological Chemistry.

[7]  J. Olefsky,et al.  G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. , 2005, Molecular endocrinology.

[8]  C. Duve.  The lysosome turns fifty , 2005, Nature Cell Biology.

[9]  O. Larsson,et al.  β-Arrestin Is Crucial for Ubiquitination and Down-regulation of the Insulin-like Growth Factor-1 Receptor by Acting as Adaptor for the MDM2 E3 Ligase* , 2005, Journal of Biological Chemistry.

[10]  O. McGuinness,et al.  Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake. , 2005, American journal of physiology. Endocrinology and metabolism.

[11]  E. Oetjen,et al.  Protein Kinase B Activity Is Sufficient to Mimic the Effect of Insulin on Glucagon Gene Transcription* , 2005, Journal of Biological Chemistry.

[12]  J. Olefsky,et al.  G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. , 2005, Molecular endocrinology.

[13]  A. Rana,et al.  Peroxisome Proliferator-activated Receptor γ Activation Can Regulate β-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway* , 2004, Journal of Biological Chemistry.

[14]  Marc Montminy,et al.  TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver , 2003, Science.

[15]  E. Oetjen,et al.  Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. , 2003, Molecular pharmacology.

[16]  Y. Kido,et al.  CEACAM1 regulates insulin clearance in liver , 2002, Nature Genetics.

[17]  P. Vollenweider,et al.  Insulin and Insulin-like Growth Factor I Receptors Utilize Different G Protein Signaling Components* , 2001, The Journal of Biological Chemistry.

[18]  E. Oetjen,et al.  Insulin Responsiveness of the Glucagon Gene Conferred by Interactions between Proximal Promoter and More Distal Enhancer-like Elements Involving the Paired-domain Transcription Factor Pax6* , 2000, The Journal of Biological Chemistry.

[19]  B. Ahrén,et al.  Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women , 2000, Diabetologia.

[20]  J D Veldhuis,et al.  Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  M. Bünemann,et al.  G‐protein coupled receptor kinases as modulators of G‐protein signalling , 1999, The Journal of physiology.

[22]  P. Bergsten,et al.  Pulsatile insulin release: role of cytoplasmic Ca2+ oscillations. , 1998, Diabetes & metabolism.

[23]  P. Cohen,et al.  Mechanism of activation and function of protein kinase B. , 1998, Current opinion in genetics & development.

[24]  I. Svendsen,et al.  Evidence for a Major Role for Glucagon in Regulation of Plasma Glucose in Conscious, Nondiabetic, and Alloxan-Induced Diabetic Rabbits , 1996, Diabetes.

[25]  L. Dick,et al.  Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin , 1996, The Journal of Biological Chemistry.

[26]  P. Lefèbvre.  Glucagon and its Family Revisited , 1995, Diabetes Care.

[27]  浩一 木佐貫.  Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion , 1995 .

[28]  E. Oetjen,et al.  Distinct properties of the cAMP-responsive element of the rat insulin I gene. , 1994, The Journal of biological chemistry.

[29]  E. Oetjen,et al.  Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. , 1993, The Journal of biological chemistry.

[30]  S. Bonner-Weir,et al.  Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. , 1990, The Journal of clinical investigation.

[31]  J. Norton,et al.  Tumor necrosis factor: immune endocrine interaction. , 1989, Surgery.

[32]  J. Treadway,et al.  Regulation of the insulin receptor kinase by hyperinsulinism. , 1989, The Journal of biological chemistry.

[33]  J. Philippe.  Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line. , 1989, The Journal of clinical investigation.

[34]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[35]  A. Golay,et al.  Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[36]  T. Gelehrter,et al.  Desensitization of hepatoma cells to insulin action. Evidence for a post-receptor mechanism. , 1981, The Journal of biological chemistry.

[37]  L. Orci,et al.  Glucagon and the A cell: physiology and pathophysiology (first two parts). , 1981, The New England journal of medicine.

[38]  L. Orci,et al.  Glucagon and the A cell: physiology and pathophysiology (second of two parts). , 1981, The New England journal of medicine.

[39]  G WhittakerP,et al.  共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .

[40]  J. Olefsky,et al.  Effects of lysosomotropic agents on insulin interactions with adipocytes. Evidence for a lysosomal pathway for insulin processing and degradation. , 1979, The Journal of biological chemistry.

[41]  P. Bennett,et al.  Stoichiometric binding and regulation of insulin receptors on human diploid fibroblasts using physiologic insulin levels. , 1979, The Journal of biological chemistry.

[42]  W. Blackard,et al.  Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. , 1978, Endocrinology.

[43]  J. Livingston,et al.  Insulin-dependent regulation of the insulin-sensitivity of adipocytes , 1978, Nature.

[44]  L. Orci,et al.  THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.